Abstract | BACKGROUND: MATERIALS AND METHOD: RESULTS: The median age was 70 years, and the gender(male/female)was 23/8 cases. NK1 receptor antagonist, 5-HT3 receptor antagonist, and dexamethasone were used as antiemetic agents in 29 patients(94%). Sixteen patients(52%)had Grade 1 or higher nausea, and 6 patients (19%)had Grade 1 or higher vomiting, and complete control of nausea and vomiting was achieved in 21 patients(68%). Nausea was significantly more frequent in patients with liver metastasis(p=0.0008), but there was no significant difference in vomiting(p=1.0000). There was no significant difference in the occurrence of CINV between chemotherapy regimens or combination of olanzapine. CONCLUSION:
|
Authors | Junji Kawada, Manatsu Mizuno, Akio Fukada, Masaya Nakano, Masatoshi Murotani, Shinnosuke Nagano, Naoki Yoneda, Shinya Kidogami, Yukako Mokutani, Tomoya Kishimoto, Yasuji Hashimoto, Hajime Hirose, Shinichi Yoshioka, Shigeyuki Tamura, Yo Sasaki |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy
(Gan To Kagaku Ryoho)
Vol. 49
Issue 4
Pg. 462-464
(Apr 2022)
ISSN: 0385-0684 [Print] Japan |
PMID | 35444136
(Publication Type: Journal Article)
|
Chemical References |
- Antiemetics
- Antineoplastic Agents
|
Topics |
- Aged
- Antiemetics
(therapeutic use)
- Antineoplastic Agents
(therapeutic use)
- Female
- Humans
- Male
- Nausea
(chemically induced, drug therapy, prevention & control)
- Retrospective Studies
- Stomach Neoplasms
(drug therapy)
- Vomiting
(chemically induced, drug therapy, prevention & control)
|